Article
Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC
2022-05-31
Abstract excerpt
<title>Abstract</title> <p>Gastric cancer is the fourth leading cause of cancer deaths worldwide. Most patients are diagnosed in the advanced stage, and inadequate therapeutic strategies and the high recurrence rate leads to the poor 5-year survival rate. Therefore, effective chemoprevention drugs for gastric cancer are urgently needed. Repurposing clinical drugs is an effective strategy for cancer chemopreventio...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bd029203-7f1d-5f69-a036-fc510dedc5ad
- DOI
- 10.21203/rs.3.rs-1628199/v1
